Hims and Liraglutide: Where a Daily GLP-1 Fits in Telehealth

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This Education Hub article covers GLP-1 therapies, weight management protocols, and the genetic variables shaping metabolic decisions. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Hims or its parent company, and no affiliate links or compensation are involved.

Liraglutide is one of the older names in the GLP-1 receptor-agonist family, and readers searching it alongside Hims usually want to know how a specific compound moves through a telehealth program. This review situates liraglutide in the broader class and explains the branded-versus-compounded distinction — balanced editorial framing, not a buying recommendation, as of April 2026.

Where liraglutide sits in the GLP-1 landscape

Liraglutide is a GLP-1 receptor agonist, in the same functional family as semaglutide and dulaglutide, and distinct from the GIP/GLP-1 dual agonist tirzepatide. As a class, these compounds act on the GLP-1 receptor to influence appetite and glucose handling. This article does not provide dosing, titration schedules, or injection technique for liraglutide; those are decisions for a prescribing clinician.

How a telehealth program handles a specific compound

Hims (Hims & Hers Health) operates as subscription telehealth: a licensed provider conducts a virtual evaluation, then writes a prescription routed to either a retail pharmacy for FDA-approved brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide. Whether any single program offers a specific compound is shown at intake — confirm the current lineup on Hims's official website rather than assuming.

Branded versus compounded: what the distinction means

A specific GLP-1 compound may reach a patient either as an FDA-approved branded product through a retail pharmacy or as a compounded preparation through a licensed 503A pharmacy. The two are regulated differently, and which pathway applies depends on the program and the compound. Reading that detail carefully matters more than the compound name alone.

Intake, access, and follow-up

The mechanics are consistent across telehealth GLP-1 programs: an intake capturing weight, medical history, and current medications; a licensed-clinician review; prescription fulfillment through a retail or compounding pharmacy; and ongoing follow-up for titration and side-effect management. Provider type, pharmacy partner, and subscription structure vary from brand to brand.

What the trial evidence covers

The GLP-1 class rests on a body of trial work. STEP studied semaglutide for weight management (The New England Journal of Medicine, 2021); SURMOUNT studied tirzepatide for weight management (NEJM 2022); SURMOUNT-OSA studied tirzepatide for obstructive sleep apnea (NEJM 2024). Trial populations and endpoints differ, and individual outcomes vary regardless of which compound is prescribed.

The variable a compound choice cannot see: your genes

Choosing a compound says nothing about the genetic terrain it acts on. GLP1R, the receptor gene targeted by every GLP-1 agonist including liraglutide, sits with FTO (fat-mass and obesity-associated), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (tied to glucose homeostasis and GLP-1 secretion). These pathway-level variants do not predict response to liraglutide or any other compound; they describe the biology being prescribed into.

PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights — including FTO, MC4R, and TCF7L2 variants that shape baseline appetite and energy-balance biology. That upstream read is the test before you invest approach, turning guesswork into an informed conversation with your provider.

Not affiliated: PlexusDx has no affiliation with Hims and no commercial relationship with any company reviewed here.

Related reading on PlexusDx: Victoza Review, Victoza Starting Dose, Buy Victoza Online, Cheap Victoza.

Compare the PlexusDx approach: the Weight Management Protocols pair semaglutide and tirzepatide with genetic context, or take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions

Is liraglutide the same as semaglutide?

No. Both are GLP-1 receptor agonists, but they are distinct molecules with different profiles. Liraglutide is one of the earlier compounds in the class, while semaglutide is newer. This review does not provide dosing or technique for either; those decisions belong to a licensed prescribing clinician after evaluation.

Does Hims offer liraglutide specifically?

Whether any telehealth brand offers a particular compound is a program-level detail shown during intake and subject to change. Rather than assume liraglutide is available, confirm the current compound lineup directly on Hims's own website, along with whether it would arrive as a branded or 503A-compounded preparation.

How does the Precision Peptide Genetic Test relate to liraglutide?

It does not predict how you will respond to liraglutide or any other compound. It reads pathway-level variants in FTO and MC4R, and TCF7L2 that describe your baseline GLP-1 and appetite biology — context that applies to the whole receptor-agonist class rather than to one specific molecule.

Where should I confirm compound and pricing details?

Only on the brand's own website. Compound availability, branded-versus-compounded sourcing, and pricing all change over time. Telehealth GLP-1 totals in this market run roughly $200 to $700+ per month as of April 2026, so treat any third-party number as unverified until you check the source.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Disclaimer: This article is educational. PlexusDx is not affiliated with Hims and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols; this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.